Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

SML1921

Sigma-Aldrich

NVP-ADW742

≥98% (HPLC)

Synonym(s):

5-[3-(Phenylmethoxy)phenyl]-7-[trans-3-(1-pyrrolidinylmethyl)cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine, NVP-ADW 742

Sign Into View Organizational & Contract Pricing

Select a Size

5 MG
$91.80
25 MG
$371.00

$91.80

Estimated to ship onApril 14, 2025

Request a Bulk Order
All Photos(1)

Select a Size

Change View
5 MG
$91.80
25 MG
$371.00

About This Item

Empirical Formula (Hill Notation):
C28H31N5O
CAS Number:
475488-23-4
Molecular Weight:
453.58
UNSPSC Code:
12352200
NACRES:
NA.77

$91.80

Estimated to ship onApril 14, 2025

Request a Bulk Order

Quality Level

100

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

N6(CCCC6)C[C@@H]1C[C@H](C1)[n]2c3ncnc(c3c(c2)c4cc(ccc4)OCc5ccccc5)N

InChI

1S/C28H31N5O/c29-27-26-25(22-9-6-10-24(15-22)34-18-20-7-2-1-3-8-20)17-33(28(26)31-19-30-27)23-13-21(14-23)16-32-11-4-5-12-32/h1-3,6-10,15,17,19,21,23H,4-5,11-14,16,18H2,(H2,29,30,31)/t21-,23-

InChI key

LSFLAQVDISHMNB-AFARHQOCSA-N

Application

NVP-ADW742 has been used as an insulin-like growth factor 1 receptor (IGF1R) inhibitor to test the effects of filamin A (FLNA) silencing in a cell proliferation assay.[1]

Biochem/physiol Actions

Insulin-like growth factor-I (IGF-I) receptor kinase inhibitor
NVP-ADW742 is a potent and selective ATP-competitive inhibitor of Insulin-like growth factor-I receptor (IGF-IR) kinase. NVP-ADW742 sensitizes cancer cell lines to multiple anticancer agents including etoposide, carboplatin, imatinib, vincristine, and doxorubicin.

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

R Catalano et al.
Cancer letters, 497, 77-88 (2020-10-20)
Adrenocortical carcinomas (ACCs) overexpress insulin-like growth factor 2 (IGF2), that drives a proliferative autocrine loop by binding to IGF1R and IR, but IGF1R/IR-targeted therapies failed in ACC patients. The cytoskeleton actin-binding protein filamin A (FLNA) impairs IR signalling in melanoma

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service